Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Reviews in Endocrine and Metabolic Disorders

Issue 6/2022

MALE GONADAL FUNCTION AND AGEING

Content (17 Articles)

Open Access Androgens

Preface

Frederick CW Wu, Ilpo T Huhtaniemi

Open Access Fertility

Reproductive axis ageing and fertility in men

Sarah Martins da Silva, Richard A Anderson

Obesity

Aging and androgens: Physiology and clinical implications

Bradley D. Anawalt, Alvin M. Matsumoto

Hypogonadism

Diagnosis of hypogonadism in ageing men

Jean-Marc Kaufman

Prostate Cancer

Testosterone treatment of late-onset hypogonadism – benefits and risks

Peter Snyder

Open Access Erectile Dysfunction

The role of testosterone in male sexual function

Giovanni Corona, Mario Maggi

Osteoporosis

Bone health in ageing men

Karel David, Nick Narinx, Leen Antonio, Pieter Evenepoel, Frank Claessens, Brigitte Decallonne, Dirk Vanderschueren

Testosterone

The anabolic applications of androgens in older adults with functional limitations

Arijeet K. Gattu, Anna L. Goldman, Ezgi Caliskan Guzelce, Francesca Galbiati, Shalender Bhasin

Open Access Prostate Cancer

Androgens, aging, and prostate health

Karin Welén, Jan-Erik Damber

Open Access Obesity

Obesity, type 2 diabetes, and testosterone in ageing men

Gary Wittert, Mathis Grossmann

Open Access Alzheimer's Disease

Testosterone, cognitive decline and dementia in ageing men

Bu B. Yeap, Leon Flicker

Open Access Antidepressant Drugs

The role of testosterone, the androgen receptor, and hypothalamic-pituitary–gonadal axis in depression in ageing Men

Richard L. Hauger, Ursula G. Saelzler, Meghana S. Pagadala, Matthew S. Panizzon

Obesity

The medicalization of testosterone: reinventing the elixir of life

Thiago Gagliano-Jucá, Mauricio Alvarez, Shehzad Basaria

Open Access Stroke

Mortality and morbidity in ageing men: Biology, Lifestyle and Environment

Erfei Zhao, Eileen M. Crimmins

Stroke

Relationships between endogenous and exogenous testosterone and cardiovascular disease in men

Arthi Thirumalai, Bradley D. Anawalt

Open Access Glucocorticoid

Sleep, testosterone and cortisol balance, and ageing men

Peter Y. Liu, Radha T. Reddy

Fertility

Animal models of male reproductive ageing to study testosterone production and spermatogenesis

David F. Carrageta, Bárbara Guerra-Carvalho, Maria Angélica Spadella, Marc Yeste, Pedro F. Oliveira, Marco G. Alves

Oct 22
Issue: 5/2022
Feb 23
Issue: 1/2023
Adrenal Disorders and Pregnancy

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits